Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

Valeant will relaunch ‘female Viagra’ drug with poor track record

Valeant Pharmaceuticals International Inc. said Tuesday it plans a U.S. relaunch of prescription drug Addyi, which is intended to treat low sexual desire in women.

The company VRX, -10.02% which is burdened with debt and desperately needs new drugs and products, positioned Addyi’s March relaunch, and that of dry mouth treatment Neutrasal, as among its more than 50 product launches globally this year.

Valeant didn’t say how much revenue it expects the relaunch to generate. The drug’s struggling 2016 sales came at a time of peak troubles for Valeant itself, with its accounting and pricing tactics under attack and debt...


More